Does Rallies show live market data for INDV?

Rallies combines live market context with ticker research for INDV, including charts, news, financials, analyst data, institutional holdings, politician trades, insider activity, and AI research where available.

INDV (Indivior Pharmaceuticals, Inc. Common Stock) Stock Analysis

Indivior Pharmaceuticals, Inc. Common Stock (INDV) is a publicly traded Healthcare sector company. As of May 20, 2026, INDV trades at $38.47 with a market cap of $4.32B and a P/E ratio of 22.16. INDV moved +1.26% today. Year to date, INDV is +3.53%; over the trailing twelve months it is +216.69%. Its 52-week range spans $7.33 to $41.00. Analyst consensus is strong buy with an average price target of $50.67. Rallies surfaces INDV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the latest INDV stock research?

Indivior Pharmaceuticals, Inc. Common Stock (INDV) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. INDV moved +1.26% today. Analyst consensus is strong buy.

INDV Key Metrics

Key financial metrics for INDV
Metric	Value
Price	$38.47
Market Cap	$4.32B
P/E Ratio	22.16
EPS	$1.68
Dividend Yield	0.00%
52-Week High	$41.00
52-Week Low	$7.33
Volume	925
Avg Volume	0
Revenue (TTM)	$1.24B
Net Income	$210.00M
Gross Margin	80.23%

Latest INDV News

Indivior launches $175M accelerated share repurchase, initial 3.7M shares delivered — May 4, 2026
Indivior Q1 Revenue Jumps 19%, SUBLOCADE Sales Climb 32%, Raises 2026 Guidance — Apr 30, 2026
Indivior Model Projects 747 Staff Hour Cuts and $22,148 Monthly Savings in Prisons — Mar 31, 2026
Indivior Prices $450M 0.625% Convertible Notes to Repay Debt, Buy Shares — Mar 13, 2026
Indivior Study: SUBLOCADE Adherence Cuts Costs 42%, Reduces Acute Care Visits — Mar 11, 2026

Recent INDV Insider Trades

Ryan Barbara bought 8 (~$248.68) on Mar 13, 2026.
Ryan Barbara bought 31 (~$1.01K) on Mar 9, 2026.
Kingsley Stuart A bought 940 (~$29.95K) on Mar 6, 2026.

INDV Analyst Consensus

4 analysts cover INDV: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $50.67.

Common questions about INDV

What can I research for INDV on Rallies?: Indivior Pharmaceuticals, Inc. Common Stock (INDV) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. INDV moved +1.26% today. Analyst consensus is strong buy.
Does Rallies show live market data for INDV?: Rallies combines live market context with ticker research for INDV, including charts, news, financials, analyst data, institutional holdings, politician trades, insider activity, and AI research where available.